Pembrolizumab + chemotherapy for advanced G/GEJ adenocarcinoma (GC): The phase III KEYNOTE-062 study

Authors :: Joseph Chao
Maria Ignez Braghiroli
Charles S. Fuchs
Y-J. Bang
Sukrut Shah
Eray Goekkurt
E. Van Cutsem
J. Tabernero
Iveta Kudaba
H.C. Chung
Hugo Castro
Uma Kher
Wasat Mansoor
Zev A. Wainberg
Lucjan Wyrwicz
K.-W. Lee
K. Shitara
Marcelo Garrido
Source :: Annals of Oncology. 30:ix43-ix44
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.

Subjects :: Oncology
medicine.medical_specialty
Chemotherapy
business.industry
Internal medicine
medicine.medical_treatment
Medicine
Adenocarcinoma
Hematology
Pembrolizumab
business
medicine.disease

Tools